{"id":730146,"date":"2023-02-09T08:20:33","date_gmt":"2023-02-09T13:20:33","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/amarin-mails-letter-highlighting-why-shareholders-should-vote-on-the-white-proxy-card-against-sarissas-harmful-proposals\/"},"modified":"2023-02-09T08:20:33","modified_gmt":"2023-02-09T13:20:33","slug":"amarin-mails-letter-highlighting-why-shareholders-should-vote-on-the-white-proxy-card-against-sarissas-harmful-proposals","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/amarin-mails-letter-highlighting-why-shareholders-should-vote-on-the-white-proxy-card-against-sarissas-harmful-proposals\/","title":{"rendered":"Amarin Mails Letter Highlighting Why Shareholders Should Vote on the WHITE Proxy Card \u201cAGAINST\u201d Sarissa\u2019s Harmful Proposals"},"content":{"rendered":"
\n

\n Letter Underscores the Change That is Being Led by Amarin\u2019s New Board<\/em>\n <\/p>\n

\n Highlights Sarissa\u2019s Track Record of Value Destruction in the Healthcare Space<\/em>\n <\/p>\n

\n Sarissa Continues to Mislead Shareholders by Distorting Facts and Promoting Misinformation<\/em>\n <\/p>\n

DUBLIN, Ireland and BRIDGEWATER., N.J., Feb. 09, 2023 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ: AMRN) (\u201cAmarin\u201d or the \u201cCompany\u201d) today announced that it has mailed a letter to shareholders in connection with the General Meeting of Shareholders urging shareholders to vote \u201cAGAINST\u201d<\/strong> all proposals on the WHITE<\/strong> proxy card. The General Meeting of Shareholders is scheduled to be held on February 28, 2023, and shareholders of record as of January 23, 2023, will be entitled to vote at the meeting.<\/p>\n

The full text of the letter being mailed to shareholders can be found at www.voteamarin.com<\/a> and follows:<\/p>\n

Time is short and the facts are clear. Act today to ensure that the Amarin Board and management team are best positioned to continue executing our transformation plan and deliver near- and long-term value for you.<\/p>\n

\n Scan this QR code to learn more about why you should vote AGAINST Sarissa\u2019s harmful proposals on the <\/em>
\n
\n
\n WHITE<\/u>
\n <\/em>
\n <\/strong>
\n proxy card today. <\/em>\n <\/p>\n

\n Please follow the instructions on the enclosed <\/em>
\n
\n
\n WHITE<\/u>
\n <\/em>
\n <\/strong>
\n proxy card and vote by telephone, internet or mail. For ADS holders, the deadline to submit your vote is 3 PM GMT (10 AM ET) February 22, 2023, and for holders of ordinary shares, the deadline is 3 PM GMT (10 AM ET) February 24, 2023.<\/em>\n <\/p>\n

\n 1.\u00a0<\/strong>
\n We are a NEW Amarin: NEW Board, NEW Management Team and NEW Strategy.<\/strong>\n <\/p>\n

The Amarin of today is a profoundly different company than 18 months ago. We recognized change was needed, and today, this new team is executing a turnaround strategy to drive value with the oversight of a purpose-built Board.<\/p>\n

Amarin is making early progress. Now is the time for us to build on our momentum to turn the Company around and create value for our shareholders. It is not the time to remove our new, highly qualified Chairman, Per Wold-Olsen, nor is it the time to nearly double the size of the Board with underqualified candidates as part of Sarissa\u2019s self-serving attempt to get on the Board.<\/p>\n

\n 2.\u00a0<\/strong>
\n Sarissa has a track record of value destruction.<\/strong>\n <\/p>\n

Sarissa claims it has created value in the healthcare space, but the facts show the opposite:<\/p>\n\n\n\n\n
\n
    \n
  • The median total shareholder return (\u201cTSR\u201d) at companies during the tenure of Sarissa-nominated directors is\u00a0NEGATIVE 24%<\/strong>.1<\/strong><\/sup><\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
\n
    \n
  • The companies that Sarissa excluded from its presentation have a median TSR of a staggering\u00a0NEGATIVE 59%<\/strong>.1<\/strong><\/sup><\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
\n